Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

BS_J6VKB1VE

low-grade glioma

95ef031c-f16e-592a-ac2c-7e50259fe39d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
low-grade glioma
cancer_type_detailed
subtype
cancer_type
low-grade glioma
age_years
8.238
sex
Male

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: HTTP GET error on 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/brain-umap/2/gsva.parquet' (HTTP 429 Too Many Requests) LINE 1: SELECT pathway_library_id, pathway_name, gsva_score FROM read_parquet('https://pub-e056b053afc04eec88337b62541f3025... ^

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1313132
breast-umap@18
D0.891
2be8d8236-4ebc-46de-a4fd-a901fec1cdce
melanoma-umap@29
0.888
3BS_25T139TX
brain-umap@2
low-grade glioma0.869
4SRR8518220
breast-umap@18
D0.869
5bae6fdb5-9df3-433c-9a4c-e5c159a62bc6
colon-landscapes@1
0.864
6TCGA-93-A4JQ-01A-11R-A24X-07
lung-landscapes@6
cohortA10.863
7e07c111b-da6e-4743-9351-77491153bec4
melanoma-umap@29
0.859
8AUR-AE6X-TTP1-A-1-0-R-A741-41
breast-umap@18
D0.857
9TCGA-93-A4JO-01A-21R-A24X-07
lung-landscapes@6
cohortA10.857
10C3N-00433
lung-landscapes@6
cohortMD20.856

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 15 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
INTERFERON_ALPHA_RESPONSE0.399Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.399Idelalisib— uncovered
ALLOGRAFT_REJECTION0.314Idelalisib— uncovered
IL6_JAK_STAT3_SIGNALING0.300Inavolisib— uncovered
INFLAMMATORY_RESPONSE0.213Idelalisib— uncovered
TNFA_SIGNALING_VIA_NFKB0.186Inavolisib— uncovered
ANGIOGENESIS0.171Remibrutinib— uncovered
KRAS_SIGNALING_UP0.165Inavolisib— uncovered
IL2_STAT5_SIGNALING0.164Idelalisib— uncovered
APICAL_SURFACE0.141Temsirolimus— uncovered
COMPLEMENT0.100Inavolisib— uncovered
KRAS_SIGNALING_DN0.021Remibrutinib— uncovered
NOTCH_SIGNALING0.015Inavolisib— uncovered
COAGULATION0.008Binimetinib— uncovered
UV_RESPONSE_DN0.005Inavolisib— uncovered